z-logo
open-access-imgOpen Access
Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producingEscherichia coliO104:H4 in adults
Author(s) -
Inge Derad,
Birgit Obermann,
Alexander Katalinic,
Nora Eisemann,
Johannes K.M. Knobloch,
Friedhelm Sayk,
Peter Wellhöner,
Hendrik Lehnert,
Werner Solbach,
Sven Süfke,
Jürgen Steinhoff,
Martin Nitschke
Publication year - 2015
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfv255
Subject(s) - medicine , eculizumab , renal function , kidney disease , dialysis , gastroenterology , shiga toxin , proteinuria , acute kidney injury , renal replacement therapy , creatinine , kidney , surgery , immunology , escherichia coli , complement system , antibody , chemistry , gene , biochemistry
Shiga toxin-producing, enteroaggregative Escherichia coli was responsible for the 2011 outbreak of haemolytic uraemic syndrome (HUS). The present single-centre, observational study describes the 1-year course of the disease with an emphasis on kidney function. Outcome data after 1 year are associated with treatment and patient characteristics at onset of HUS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom